Skip to main content

Free UK delivery · Batch tested

Tesamorelin — 98%+ purity research compound vial, UK stocked (HelixCore Peptides)
UK Stock

Tesamorelin

Synthetic stabilised GHRH(1-44) analogue supplied for in-vitro GHRH receptor research.

Purity

98%+ (per source specifications)

Form

Lyophilised Powder

Storage

-20°C lyophilised · store at 2–8°C once reconstituted

CAS Number

218949-48-5

Mol. Weight

5135.9 g/mol

This batch tested at 99.4% purity (HPLC). View certificate ↓

£64.99

Free UK delivery

1
In UK stock now · Free Royal Mail Tracked 24 delivery
Free tool: Tesamorelin reconstitution calculator →
Research Use Only. Sold strictly for in-vitro laboratory research. Not for human or veterinary use, medical, therapeutic or diagnostic application.
Plain packaging suitable for laboratory deliveries.

About Tesamorelin

What it is

Tesamorelin is a growth-hormone-releasing hormone analogue stabilised by the addition of a trans-3-hexenoyl group at one end. It is licensed in the United States as Egrifta for HIV-associated lipodystrophy. The licensed product is a specific pharmaceutical preparation for that indication and is not what is supplied here.

How it is understood to work

It binds the GHRH receptor. The added group protects it from dipeptidyl peptidase-4, the enzyme that rapidly degrades natural GHRH, giving it a longer working life than sermorelin while acting at the same receptor. Like other GHRH analogues it works through the pituitary, so the body's own regulatory feedback remains in play.

What research has looked at

Endocrine research on the GH axis, and adipose tissue studies, particularly visceral fat, which reflects the indication it was developed for.

Handling and storage

Lyophilised. Reconstitute gently, refrigerate, and avoid freeze-thaw cycling.

Supplied for in-vitro laboratory research only. Nothing above describes a dose, a protocol, or a use in humans or animals, and none of these compounds is a licensed medicine in the UK.

Certificate of Analysis

Purity (HPLC)

99.4%

Batch
26030604-03
TestSpecificationResult
AppearanceWhite or off-white powderWhite powder
Identity (mass spectrometry)5135.9 ± 1.05136.6
Purity (HPLC)Not less than 98.0%99.4%
Bacterial endotoxinsNot more than 10 EU/mgConforms
Water content (Karl Fischer)Not more than 8.0%3.4%
Residual solventsWithin limitsConforms

This batch of Tesamorelin complies with specification. Figures are taken from the manufacturer certificate of analysis for this batch.

Research Information

Tesamorelin is a synthetic 44-amino-acid GHRH analogue stabilised by an N-terminal trans-3-hexenoyl modification. It's studied for its role in metabolic and visceral fat research. Researchers are interested in how stabilised GHRH analogues affect lipid metabolism pathways in cell-culture studies, distinct from the broader growth hormone signalling research. Most published work has used adipocyte and hepatocyte cell models to examine these mechanisms.

Research areas

  • Stabilised GHRH analogue research
  • Adipocyte cell-line studies
  • Hepatocyte lipid metabolism research
  • GHRH receptor activation duration studies

Analytical methods

Identity and purity are typically confirmed at source by high-performance liquid chromatography (HPLC) and mass spectrometry.

Storage and handling

Store lyophilised at -20°C, away from moisture and direct light. Once reconstituted, store at 2–8°C and use within the timeframe specified on the source datasheet.

For Research Use Only. Not for human or veterinary use.

Batch tested

Every batch is tested for identity and purity, and we publish the certificate.

UK dispatch

UK-stocked. Orders placed before 2pm dispatch the same business day via Royal Mail Tracked 24. Free UK shipping on every order. We ship to UK addresses only.

Frequently asked questions